Risk of Alzheimer's disease is associated with a very low-density lipoprotein receptor genotype in Northern Ireland

S P McIlroy, M D Vahidassr, D A Savage, C C Patterson, J T Lawson, A P Passmore

Research output: Contribution to journalArticlepeer-review

24 Citations (Scopus)

Abstract

The epsilon-4 allele of apolipoprotein E (APOE) is associated with increased risk of Alzheimer's disease (AD), but the pathogenic mechanism is unknown. The 5-repeat allele of a CGG repeat polymorphism in the 5' untranslated region of the very low-density lipoprotein receptor (VLDL-R) gene, a receptor for apoE, has been found to be associated with increased risk of AD in a Japanese population. Other groups have been unable to replicate this in American Caucasian populations. A case-control study utilizing a clinically well-defined group of late-onset AD patients (n = 108) and age- and sex-matched control subjects (n = 108) from Northern Ireland was performed to test this association in a relatively homogeneous population. The 9,9 genotype of the VLDL-R was found to be significantly increased in patients compared to controls (P = 0.003; Pcorr = 0.035), leading to an increased risk of AD to subjects with this genotype (OR = 3.9; 95% CI, 1.52-11.25). In contrast to results from the Japanese study, the 5-repeat allele was found to be significantly reduced in the patient group when compared to controls (P = 0.008; Pcorr = 0.047). The results from this study suggest that individuals who have the 9,9 genotype of the VLDL-R gene are at increased risk of AD in Northern Ireland.
Original languageEnglish
Pages (from-to)140-4
Number of pages5
JournalAmerican Journal of Medical Genetics
Volume88
Issue number2
Publication statusPublished - 1999

Fingerprint Dive into the research topics of 'Risk of Alzheimer's disease is associated with a very low-density lipoprotein receptor genotype in Northern Ireland'. Together they form a unique fingerprint.

Cite this